USA Compression Partners heads into the back half of May with its best weekly performance in months, while the Street edges cautiously higher on the name — a combination that sets up a quiet but interesting tension between price momentum and subdued analyst conviction.
The rally is the story this week. USAC gained 6.5% on Tuesday alone and closed Wednesday at $29.22, a 6.8% weekly advance and nearly 6% higher than a month ago. That move came in the wake of a Q1 earnings print on May 5 that generated almost no immediate market reaction — the stock moved barely 0.2% on the day — but then gained over 8% in the following five sessions, suggesting the market digested the results positively on reflection rather than reflexively.
The lending market offers little in the way of short-side pressure. Short interest has drifted gently lower over the past six weeks — from around 3.1% of the free float in mid-April to 3.0% now — and borrow conditions are extremely loose. The cost to borrow has fallen sharply, down 37% on the week to just 0.32% annualised, a fraction of levels seen in late April. Availability remains ample by any measure, with utilisation running at only about 17% of the available lending pool, well below the 52-week high of nearly 85%. Short sellers are not crowding in; the short score of 52.9 is resolutely mid-range and has barely moved over the past fortnight. Options positioning reinforces the picture — the put/call ratio of 0.52 is modestly above its 20-day average of 0.49, but the z-score of 0.69 is well within normal range, nowhere near the kind of defensive skew that would signal genuine concern.
The analyst picture is one of grudging acceptance rather than conviction. Citigroup raised its price target to $28 from $26 today while keeping a Neutral rating — a move that at least puts it closer to where the stock is actually trading, at $29.22. The mean analyst target across the coverage group has reached $29.33, almost exactly at the current price, implying the Street sees fair value here rather than significant upside. Stifel lifted its target to $30 in February; JPMorgan, the most sceptical voice in coverage, holds an Underweight with a $25 target. The constellation of Neutrals and Hold-equivalents across Citigroup, Stifel, Mizuho, and RBC paints a picture of a stock that analysts consider well-priced but unremarkable. On valuation, EV/EBITDA runs at 8.4x on ORTEX data, with the ratio edging higher over the past 30 days as the price has appreciated. The dividend score ranks in the 85th percentile — a meaningful data point for a midstream MLP like USAC, where yield support matters to the income investor base.
The ownership structure is concentrated in ways worth noting. Energy Transfer holds 26% of units, J-W Energy Company owns another 12.5%, and ALPS Advisors — a passive MLP-focused vehicle — added 1.46 million units in the most recent filing. Together, the top three holders control over half the float, which naturally compresses the tradeable base. Insider activity since February shows a net positive in unit terms — a director's $268k purchase in late February outweighed modest sells from the General Counsel — though the most recent declared trades are now roughly three months stale.
The next scheduled earnings call arrives on August 4. Between now and then, the watch points are whether the analyst cluster upgrades out of its Neutral holding pattern as the stock continues to grind through analyst targets, and whether the energy services peer group — which had a distinctly weaker week than USAC, with BKR down 3.7% and XPRO off over 11% — begins to drag on the premium USAC has quietly rebuilt.
See the live data behind this article on ORTEX.
Open USAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
